the past year, we have been focused on building global scientific awareness and encouraging adoption of our chelator platform across the therapeutic radiopharmaceutical community," said Bill Cupelo, Chief Business Officer of Ratio. "We are proud to...
products, as well as making sustainable business decisions for the betterment of society and global health. For more information, please visit https://samsungbiologics.com/
81 percent had one prior LOT (range, 1−3), and 65 percent had progressed within 12 months of first-line treatment. More information on this trial can be found at https://www.clinicaltrials.gov/ (NCT: 04663347). About Epcoritamab: Epcoritamab is an...
in the generation of predictive human disease models is pleased to announce the launch of its modular iPSCore™ platform. iXCells’ mission is to empower life science researchers and patient foundations to advance personalized therapies and...
to delivering innovative therapies that help patients stay ahead of their disease.” ROS1+ NSCLC is a rare and aggressive form of lung cancer, accounting for approximately 2% of new NSCLC cases, or about 3,000 new diagnoses of advanced disease...
the European Economic Area, the UK and Switzerland. “This partnership marks a major milestone in our mission to transform how rare disease therapies reach patients in Europe,” said Adam Plich, Founder and CEO of Avanzanite. “We provide biotech...
Lubrizol announces that an Apisolex™ polymer excipient-enabled drug formulation is in Phase 1 clinical trials. Introduced to the market in 2022, Apisolex polymer excipient is a polyamino acid-based polymer that enhances the solubility of BCS Class...
instruments, accessory products, educational resources, and contract assay services that are used by scientists performing stem cell, immunology, cancer, regenerative medicine, and cellular therapy research globally. About CollPlant CollPlant is a...
while cutting consumable costs four-fold and in-lab labor by half compared to current generation technologies. These transformative capabilities give the pharmaceutical industry the practical means to pivot beyond animal testing and into truly...
and ensures optimum pharmaceutical quality. This innovation marks a decisive step in the development of new combined formulations, bringing improved clinical benefits for patients in many fields, such as ophthalmology and drug delivery. This €12...
overdose from synthetic opioids, including oral fentanyl. SOOPR utilizes a proprietary long-acting naloxone reversal formulation with faster onset kinetics versus Narcan® delivered via long-acting injection (LAI) technology. The technology is...
dermal and soft tissue fillers with Allergan, an AbbVie company, the global leader in the dermal filler market. For more information please visit http://www.collplant.com.
in children and adolescent patients treated with TNF blockers including adalimumab products. See additional safety information below. The interchangeability designation was based on clinical data from a randomized, double-blind, 1:1 ratio,...
facilitate safe and efficient patient care, Avenacy strives to be a trusted partner for essential medications. For more information, please visit http://www.avenacy.com/.
Eden, the leading health platform connecting individuals with licensed providers and pharmacies focused on metabolic health, today announced expanded access to a pharmacy-grade compounded glutathione injection protocol. The therapy is now...
are drugs listed on the FDA’s Essential Medicines List. To learn more, visit our More in America page. IMPORTANT SAFETY INFORMATION: Do not inject into buttocks, digits, hands, or feet. Avoid extravasation into tissues, which can cause local...
Fresenius Kabi, an operating company of Fresenius, and Formycon AG, announced that the U.S. Food and Drug Administration (FDA) designated Otulfi® (ustekinumab-aauz) as an interchangeable biosimilar to the reference product Stelara® (ustekinumab)....
joint care supplement brand1 introduced its new Osteo Bi-Flex® Advanced Omega-3 Joint Complex supplement. This new formula helps support joint and whole body health by combining 100 mg of Joint Shield 5-LOXIN Advanced®, a highly concentrated herbal...
science into real-world solutions for chronic diseases such as obesity, diabetes, and inflammatory conditions. For more information please visit, https://www.noster.inc/jp/
from the French government to accelerate the advancement and scaling up of Eligo's proprietary topical gene delivery platform, designed to enable local production of therapeutic biologics directly by skin-resident bacteria. This grant follows...
